Two Sigma Securities’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-27,600
Closed -$4.62M 2616
2019
Q2
$4.62M Buy
27,600
+18,800
+214% +$2.6M 0.05% 253
2019
Q1
$1.29M Sell
8,800
-8,100
-48% -$1.17M 0.01% 466
2018
Q4
$2.26M Sell
16,900
-98,800
-85% -$16.2M 0.03% 328
2018
Q3
$22M Buy
115,700
+39,500
+52% +$7.26M 0.14% 83
2018
Q2
$12.7M Sell
76,200
-30,300
-28% -$4.86M 0.06% 228
2018
Q1
$17.9M Buy
106,500
+105,200
+8,092% +$17.6M 0.1% 176
2017
Q4
$213K Buy
+1,300
New +$233K 0.01% 1263

Other funds holding AGN

Two Sigma Securities's AGN Position: Q1 2020 in Review

Two Sigma Securities sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 5,492 shares — an estimated $1.03M sold.

Two Sigma Securities first reported a position in AGN in Q3 2015 and held it in 17 quarters. The position peaked at $4.79M in Q2 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Two Sigma Securities reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Two Sigma Securities sold 5,492 Allergan plc shares in Q1 2020, an estimated $1.03M.
  • Two Sigma Securities first reported a position in Allergan plc in Q3 2015 and held it in 17 quarters.
  • Two Sigma Securities's Allergan plc position peaked at $4.79M in Q2 2019.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Two Sigma Securities's 13F filing for Q1 2020, filed 15 May 2020.